Association of polymorphisms of the MMP-2 and TIMP-2 genes with the risk of endometriosis in North Chinese women

Fertility and Sterility

Volumn 90, Issue 5, 2008, Pages 2023-2029

  Kang, Shan ^a   Zhao, Xi Wa ^a   Wang, Na ^a   Chen, Shu Cheng ^a   Zhou, Rong Miao ^a   Li, Yan ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CHINESE; CONTROL GROUP; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE INHIBITOR OF METALLOPROTEINASE 2 GENE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; YOUNG ADULT;

EID: 55149089073     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.09.068     Document Type: Article

References (30)

1. Goldman M.B., and Cramer D.W. The epidemiology of endometriosis. Prog Clin Biol Res 323 (1990) 15-31
2. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4 (1993) 197-250
3. Aimes R.T., and Quigley J.P. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 270 (1995) 5872-5876
4. Xie T.X., Wei D., Liu M., Gao A.C., Ali-Osman F., Sawaya R., et al. State activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23 (2004) 3550-3560
5. Chung H.W., Lee J.Y., Moon H.S., Hur S.E., Park M.H., Wen Y., et al. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 78 (2002) 787-795
6. Gilabert-Estelles J., Estelles A., Gilabert J., Castello R., Espana F., Falco C., et al. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 18 (2003) 1561-1622
7. Huang H.F., Hong L.H., Tan Y., and Sheng J.Z. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril 81 (2004) 1235-1239
8. Ye S. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19 (2000) 623-629
9. Price S.J., Greaves D.R., and Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276 (2000) 7549-7558
10. Yu C., Zhou Y., Miao X., Xiong P., Tan W., and Lin D. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res 64 (2004) 7622-7628
11. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74 (1997) 111-122
12. DeClerck Y.A., Darville M.I., Eeckhout Y., and Rousseau G.G. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 139 (1994) 185-191
13. Vairaktaris E., Yapijakis C., Yiannopoulos A., Vassiliou S., Serefoglou Z., Vylliotis A., et al. Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol Rep 17 (2007) 963-968
14. Zhou Y., Yu C., Miao X., Tan W., Liang G., Xiong P., et al. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25 (2007) 399-404
15. Miao X., Yu C., Tan W., Xiong P., Liang G., Lu W., et al. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 63 (2003) 3987-3990
16. Hegab A.E., Sakamoto T., Uchida Y., Nomura A., Ishii Y., Morishima Y., et al. Association analysis of tissue inhibitor of metalloproteinase2 gene polymorphisms with COPD in Egyptians. Respir Med 99 (2005) 107-110
17. The American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 43 (1985) 351-352
18. Miller S.A., Dybes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16 (1988) 1215
19. Qin H., Sun Y., and Benveniste E.N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274 (1999) 29130-29137
20. Pan M.R., and Hung W.C. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. Proc Natl Acad Sci USA 277 (2002) 32775-32780
21. Xu E., Lai M., Lv B., Xing X., Huang Q., and Xia X. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun 324 (2004) 999-1003
22. Lin S.C., Lo S.S., Liu C.J., Chung M.Y., Huang J.W., and Chang K.W. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 33 (2004) 405-409
23. Zhou Y., Yu C., Miao X., Wang Y., Tan W., Sun T., et al. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. Carcinogenesis 26 (2005) 117-1121
24. Nemec P., Goldbergova M., Swobodnik T., Polaskova D., Soucek M., and Vasku A. Polymorphism of gene promoter region for MMP-2 in rheumatoid arthritis. Vnitr Lek 52 (2006) 348-354
25. Rollin J., Regina S., Vourc'h P., Iochmann S., Blechet C., Reverdiau P., et al. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Lung Cancer 56 (2007) 273-280
26. Holla L.I., Fassmann A., Vasku A., Goldbergova M., Beranek M., Znojil V., et al. Genetic variations in the human gelatinase A (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis. J Periodontol 76 (2005) 1056-1060
27. Hirano K., Sakamoto T., Uchida Y., Morishima Y., Masuyama K., Ishii Y., et al. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 18 (2007) 748-752
28. Faisst S., and Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 20 (1992) 3-26
29. O-Charoenrat P., and Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol 42 (2006) 257-267
30. Wu C.Y., Wu M.S., Chen Y.J., Chen C.J., Chen H.P., Shun C.T., et al. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer 43 (2007) 799-808